Comment on “Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis” by Prokopidis et al.
Journal of Cachexia, Sarcopenia and Muscle · 2023
DOI: 10.1002/jcsm.13365 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2023. Verfasst von Xiaoming Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The People's Hospital of Baoan Shenzhen, The Second Affiliated Hospital of Shenzhen University, Shenzhen, China. Hauptthemen laut MEDLINE: Sarcopenia. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Medikationssicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Emergency, The People's Hospital of Baoan Shenzhen, The Second Affiliated Hospital of Shenzhen University, Shenzhen, China.
ORCID-Profile: Xiaoming Zhang
Zitieren
APA
Zhang, X., & Yang, Y. (2023). Comment on “Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis” by Prokopidis et al. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13365
Vancouver
Zhang X, Yang Y. Comment on “Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis” by Prokopidis et al. Journal of Cachexia, Sarcopenia and Muscle. 2023. doi:10.1002/jcsm.13365
BibTeX
@article{Zhang2023,
author = {Zhang, Xiaoming and Yang, Yunzhi},
title = {Comment on “Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis” by Prokopidis et al},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2023},
doi = {10.1002/jcsm.13365}
}
EUVIMED